
Many AD treatment goals focus on clinical manifestations, so that if a patient is free of lesions, their disease is considered well controlled. However, the inflammatory process underlying AD reaches far beyond the skin, affecting patients in unique ways at different stages of their lives. Education on the importance of treating AD beyond the skin and altering the treatment approach to fit the individual patient will help improve clinical management and reduce long-term patient burden.
In recognition of World Digestive Health Day, ADVENT is providing medical education resources to increase awareness of eosinophilic esophagitis (EoE).
Expert gastroenterologist Dr. Ikuo Hirano highlights the endoscopic features in EoE and reviews the EREFS scoring system to assess disease activity.
Expert gastroenterologist Dr. Ikuo Hirano reviews the histologic features of EoE and provides insights on their assessment.
Join Dr. Nirmala Gonsalves as she reviews symptoms of EoE and tools to assess symptoms in patients with EoE.
Join Dr. Nirmala Gonsalves as she reviews some of the tools to assess quality-of-life outcomes in patients with EoE.
Hear Dr. Ulrike von Arnim discuss the expert recommendations for monitoring patients with EoE in routine clinical practice.

Prof. Peter Hellings describes how type 2 inflammation drives CRSwNP.

Highlights from the ADVENT symposium at the 2023 World Congress of Dermatology in Singapore.
Want to test your EoE knowledge while learning more about the patient journey? Try EoE Quest, an engaging and educational interactive experience.
Dr. Milli Gupta emphasizes the need to regularly monitor multiple disease domains when assessing treatment response, not just EoE symptoms.
Profs. Greuter, Savarino, and Giordano discuss best practices for EoE identification, multidimensional EoE assessment, and transition of care.